Dossier Evaluation status

Dossier Evaluation status

Data platform availability banner - dossier evaluation status

The new ECHA CHEM database has been released by ECHA. See for more information on the transition to ECHA CHEM.  More

Please be aware that REACH registration data on the current Dissemination Platform (accessible through the magnifying glass icon in the table) is no longer maintained; it remains frozen as of 19th May 2023. As shown in the support page we hope to move the dossier evaluation information to ECHA CHEM by the end of 2024. Until then, while the assessment status will be updated here, the corresponding registration dossiers will be available only on ECHA CHEM.

We appreciate your understanding during this transition period.


 

Dossier Evaluation status

ECHA’s dossier evaluation process covers compliance checks and the examination of testing proposals. By consulting the table below, you can find out whether ECHA has started to evaluate dossiers for a particular substance and follow the progress through the evaluation process.

The table below displays the type, scope and status of the assessment undertaken for a given dossier. The decision date and the non-confidential version of the decision are published shortly after the decision has been adopted.

Before publishing the non-confidential version of an adopted decision on its website, ECHA consults the addressees of the decision on this version. ECHA systematically removes any personal data from the non-confidential version of a decision. Some sections may also be redacted based on justified claims by registrants, regarding information confidential or deemed to harm their commercial interest if disclosed.

Check the expandable boxes below for more details.

 

Content of the table

Identifiers of the substance: Name (as on the Dissemination website); EC/List number (European Community number / List number assigned by ECHA); CAS number (also called the Chemical Abstract Service Registry Number or CAS RN).

Decision type can be ‘CCH’ for Compliance Check Evaluation and ‘TPE’ for Testing Proposal Evaluation.

Scope refers to the scope of the evaluation and can be:

  • Targeted: The compliance check focuses only on some endpoints.
  • Comprehensive: The compliance check focuses on all relevant endpoints under ECHA’s strategy.
  • Testing proposal: The assessment focuses on the testing proposals submitted by the registrants.

Status reports the current position of the dossier in the dossier evaluation process and can be:

  • Under assessment: The evaluation of the dossier has formally started.
  • Ongoing: The registrants have received the draft decision - The dossier retains this status until the decision is adopted or the evaluation is otherwise concluded.
  • Information requested: The registrants have received the adopted decision with the deadline for providing the requested information.
  • Follow-up: The deadline set in the adopted decision has passed, and ECHA is assessing whether the information requested in the decision has been provided in the dossier update - This follow-up may also involve the national enforcement authorities.
  • Concluded: The evaluation is closed.
    In most cases, this means that the registrant has responded to the adopted decision with compliant information. However, as in some cases an evaluation is concluded at an earlier stage, an adopted decision is not always available for every evaluation marked as concluded.

Decision date reports the date on which the adopted decision was sent to the registrants.

Decision displays a non-confidential version of the adopted decision once available.

Latest update indicates the date of the latest automatic update carried out by ECHA’s information systems.

Unless confidentiality is claimed on the substance identifiers, you can access the disseminated registration dossiers for the substance in ECHA CHEM. From the table below, click on the substance name link to access the Substance Infocard. From there you will find a link to direct you to the ECHA CHEM substance Dashboard and the REACH registration dossier(s). You can also go directly to ECHA CHEM and search with substance identifiers. 

The magnifying glass icon leads to information on the current dissemination platform that has not been updated since May 2023. We apologise for the inconvenience and appreciate your understanding during the transition period. 

You can access additional information in ‘Details’ view, by clicking on the eye icon:

  • Substance identifiers
  • Decision type (CCH or TPE), scope and status of the evaluation, as in the main table
  • Decision’s deadline(s): The deadline(s) for requested information contained in the decision, should the decision contain more than one deadline
  • Appeal information: If the registrants have appealed against the adopted decision, a link to the Board of Appeal’s announcement document is provided.

 

How to read the table

ECHA’s information systems automatically update the status of dossier evaluations during the process. For transparency reasons, all dossier evaluation decisions will remain published. This also applies if the registrants have appealed or have updated the registration dossier as requested in the decision.

It is for the reader to verify the status of an evaluation: check the deadline of the decision, the indicated status of the evaluation, and the content of the registration dossier. The most recent registration data on a substance is available in the ECHA CHEM database; check also whether the Board of Appeal has taken a decision regarding any appeal.

 

Important notes:

  • The dossier evaluation decisions may not apply to all registrants that are part of a joint registration.
  • There may be a delay between the decision date and the actual publication of the adopted decision, which corresponds to the consultation on its non-confidential version and addressing any comments from the registrants.
Last updated 18 March 2024. Database contains 4138 unique substances/entries.
Filter the list
Decision's deadline:
Decision date:

The List does not contain any Substances.
Decision    
251-020-3
32388-55-9
CCH
Targeted
Concluded
27-Oct-2016
26-Nov-2022
View
Details
251-020-3
32388-55-9
CCH
Comprehensive
Concluded
07-Dec-2018
31-Aug-2023
View
Details
219-943-6
2580-56-5
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
265-449-9
65113-55-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
265-449-9
65113-55-5
TPE
Testing Proposal
Concluded
16-Mar-2015
26-Nov-2022
View
Details
255-288-2
41272-40-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
244-751-4
22042-96-2
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
244-751-4
22042-96-2
CCH
Targeted
Concluded
25-Oct-2016
26-Nov-2022
View
Details
244-751-4
22042-96-2
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
239-931-4
15827-60-8
CCH
Targeted
Concluded
26-Nov-2022
View
Details
239-931-4
15827-60-8
CCH
Targeted
Concluded
26-Nov-2022
View
Details
252-156-6
34690-00-1
TPE
Testing Proposal
Concluded
23-Nov-2018
26-Nov-2022
View
Details
234-319-3
11097-59-9
CCH
Targeted
Concluded
05-Nov-2014
26-Nov-2022
View
Details
234-319-3
11097-59-9
CCH
Targeted
Concluded
20-Nov-2014
26-Nov-2022
View
Details
234-319-3
11097-59-9
CCH
Targeted
Concluded
05-Nov-2014
26-Nov-2022
View
Details
251-908-0
34274-28-7
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
248-660-0
27794-93-0
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
243-900-0
20592-85-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
243-900-0
20592-85-2
TPE
Testing Proposal
Concluded
09-Jun-2020
26-Nov-2022
View
Details
-
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
-
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
-
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
-
-
CCH
Comprehensive
Concluded
14-Apr-2011
26-Nov-2022
View
Details
948-969-7
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
948-969-7
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
-
-
CCH
Targeted
Concluded
22-Mar-2023
View
Details
484-360-8
-
CCH
Targeted
Concluded
28-Nov-2014
26-Nov-2022
View
Details
484-360-8
-
TPE
Testing Proposal
Concluded
26-Sep-2017
26-Nov-2022
View
Details
468-970-1
-
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
-
-
CCH
Comprehensive
Concluded
17-Apr-2023
View
Details
700-674-2
-
CCH
Targeted
Concluded
26-Oct-2023
View
Details
-
-
CCH
Comprehensive
Concluded
29-Feb-2024
View
Details
939-704-6
-
CCH
Comprehensive
Concluded
05-Jul-2019
26-Nov-2022
View
Details
273-688-5
69011-06-9
CCH
Targeted
Concluded
26-Nov-2022
View
Details
273-688-5
69011-06-9
CCH
Targeted
Concluded
11-Nov-2013
26-Nov-2022
View
Details
248-573-8
27614-71-7
CCH
Targeted
Concluded
26-Nov-2022
View
Details
824-263-3
2196165-14-5
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
945-577-8
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
945-577-8
-
TPE
Testing Proposal
Concluded
18-Oct-2022
06-Jan-2023
View
Details
CGL 384; TINUVIN 384
407-000-3
127519-17-9
CCH
Targeted
Concluded
26-Nov-2022
Details
1-DODECENE DIMER, HYDROGENATED; ALKANE 2
417-060-2
151006-61-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
BRAUN HM 2763; BROWN HM 2763; BRUN HM 2763; BRUNO HM 2763
404-540-1
-
CCH
Targeted
Concluded
20-Dec-2011
26-Nov-2022
View
Details
BRAUN HM 2763; BROWN HM 2763; BRUN HM 2763; BRUNO HM 2763
404-540-1
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
MCP 968
410-190-0
132983-41-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
ACETATE DPMA ACROSOLV; ACROSOLV DPMA ACETAT; ACROSOLV DPMA ACETATE; DOWANOL DPMA; DOWANOL DPMA GLYCOL ETHER; DOWANOL DPMA GLYKOL ETHER; ETHER DE GLYCOL DPMA DOWANOL
406-880-6
88917-22-0
CCH
Comprehensive
Concluded
24-Oct-2011
26-Nov-2022
View
Details
KEROFLUX ES 3241
406-640-0
136920-07-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
EXPERIMENTAL CROSSLINKER S17762-80(S); MELAMINE BASED CROSSLINKER (MBC); TACT
420-390-1
187547-46-2
CCH
Targeted
Concluded
31-May-2011
26-Nov-2022
View
Details
SPE 93279
414-420-0
-
TPE
Testing Proposal
Concluded
23-Mar-2015
26-Nov-2022
View
Details
CASSIFFIX
422-040-1
426218-78-2
CCH
Comprehensive
Concluded
20-Apr-2016
26-Nov-2022
View
Details
TINUVIN 123
406-750-9
129757-67-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details

Export search results to: